Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

Post-mortem brain tissue from 15 patients dying with a diagnosis of senile dementia of Alzheimer type (SDAT) was compared with tissue obtained from 16 control patients at routine post-mortem. A significant fall in choline acetyltransferase (ChAT) activity was observed in the cortex, hippocampus and amygdala of the SDAT cases and was maximal in the temporal cortex. The fall in ChAT activity observed in the temporal cortex was accompanied by a significant reduction (47%) in immunoreactive somatostatin.     

Senile dementia and Alzheimer's disease: lack of changes of the cortical content of quinolinic acid

The content of Quinolinic Acid (QUIN) was fragmentographically measured in the frontal, parietal and temporal cortex obtained at autopsy from patients affected by Alzheimer's disease-senile dementia Alzheimer type (AD/SDAT) or matched controls. The density of large cholinergic neurons in the nucleus basalis magnocellularis and the density of plaques in the hippocampal formation, parietal and frontal cortex of these patients was also evaluated in order to obtain a quantitative estimation of the Alzheimer type changes. In the three cortical areas studied, the content of QUIN was similar in AD/SDAT patients and age matched controls. The AD/SDAT patients had an important reduction of the number of large cholinergic neurons in the nucleus basalis magnocellularis and a much higher density of plaques in cortex and in hippocampus than age matched controls. The data reported here do not support the possibility than an accumulation of QUIN plays a role in the neuronal degeneration occurring in the cortex of patients affected by AD/SDAT.     

Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex

Despite a 34% decrease in the activity of choline acetyltransferase (ChAT) in the rat cerebral cortex following lesions of the nucleus basalis, there were no changes in the Bmax of the antagonist ligands [3H]quinuclidinyl benzilate ((-)-[3H]QNB) or (-)-[3H]N-methylscopolamine ((-)-[3H]NMS). Furthermore, this treatment produced no significant change in the proportions or affinities of muscarinic receptors having high and low affinity for pirenzepine or (-)-NMS. These data indicate that putative M2 muscarinic receptors are not restricted to ChAT-containing neurons in rat cerebral cortex. In senescent compared to mature rats there was no significant loss of ChAT activity although a significant reduction in the Bmax of both (-)-[3H]QNB and (-)-[3H]NMS binding was observed. However, no changes in the competition of pirenzepine or (-)-NMS for the remaining (-)-[3H]QNB binding sites were observed. Therefore, there is no evidence for any differential regulation of either putative muscarinic receptor subtype in response to cholinergic deafferentation or as a function of the natural aging process.     

大鼠隔－斜带复合体中含小白蛋白蛋白和含胆碱乙酰化酶的神经元

用免疫细胞化学ＰＡＰ法，对成年大白鼠隔－斜带（Ｓ－ＤＢ）复合体中，含小白蛋白（ＰＶ）神经元的分布和形态学进行了研究，并与含胆碱乙酚化酶（ＣｈＡＴ）神经元的观察进行了比较。含ＰＶ神经元主要位于内侧隔核（ＭＳ）、斜带垂直支（ｖＤＢ）和斜带水平支（ｈＤＢ）。ＰＶ免疫反应神经元的形状和大小在Ｓ－ＤＢ复合体的各个核区或同一核区都不相同，表明这些神经元具有多样的形态学特征。在整个Ｓ－ＤＢ复合体中，含ＰＶ和含ＣｈＡＴ神经元的比例，各占ＰＶ和ＣｈＡＴ阳性反应细胞总数的４７／和５３／，在ＭＳ、ｖＤＢ和ｈＤＢ中，ＰＶ免疫反应神经元的比例分别为３８％、５４％和５９．５％，其余为含ＣｈＡＴ的胆碱能神经元。     

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR

HLA-DR is a class II cell surface glycoprotein of the human histocompatibility complex usually expressed on the surface of cells that are simultaneously presenting foreign antigen to T-lymphocytes. Using immunohistochemical procedures with two specific monoclonal antibodies to HLA-DR, HLA-DR-positive reactive microglia were found in gray matter throughout the cortex of postmortem brains of patients with senile dementia of the Alzheimer type (SDAT) and were particularly concentrated in the areas of senile plaque formation. Double immunostaining with antibodies to glial fibrillary acidic protein (GFAP) showed that the HLA-DR-positive cells were different from the reactive astrocytes although the occasional positively staining giant astrocyte was also seen. Small numbers of resting microglia were HLA-DR-positive in white matter of both normal and SDAT brains. The SDAT cases also had reduced cortical choline acetyltransferase (ChAT) levels. In the 11 brains studied, the number of hippocampal HLA-DR-positive cells was positively correlated with the numbers of plaques and negatively correlated with average cortical ChAT.     

The fate of the large striatal interneurons expressing calretinin in Huntington's disease

Huntington's disease (HD) is characterized by the atrophy of the striatum due to losses of projection neurons, while interneurons are relatively spared. However, little is known about the fate of the large interneurons that express calretinin (Cr) in HD. We addressed this issue by applying a double immunofluorescent labeling technique to postmortem striatum from HD patients and controls. We compared the distribution and density of Cr-positive (+) interneurons and their degree of choline acetyltransferase (ChAT) coexpression in normal and HD cases. Large interneurons containing only Cr, ChAT, or both occurred in the normal human striatum and a twofold decrease in the density of Cr+/ChAT+ and Cr-/ChAT+ neurons was recorded in HD striatum compared to controls. However, studies undertaken with neurokinin-1 receptor as a marker of large Cr+ and ChAT+ neurons revealed that these neurons are selectively spared in HD. Hence, the apparent decrease in the number of Cr+/ChAT+ and Cr-/ChAT+ neurons in HD is better explained by a diminution in the expression of Cr and ChAT than by the degeneration of these cells. Altogether, our data suggest that neurodegenerative processes at play in HD affect the expression of Cr and ChAT in the large striatal interneurons without causing their death.     

Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease

5-Hydroxytryptamine (5-HT) and choline acetyltransferase (ChAT) were assayed in amygdala, cingulate cortex and caudate nucleus of post-mortem brains from 7 cases of Down's syndrome (6 with the neuropathological features of Alzheimer's disease and one with no such features), 9 cases of Alzheimer's disease and 12 controls. 5-HT was markedly reduced in all 3 areas of the pathologically affected Down brains, unaltered in the Down brain with no Alzheimer pathology and reduced in the amygdala and cingulate cortex of the Alzheimer brains. ChAT showed a similar pattern of reduction. These results supply biochemical evidence that 5-hydroxytryptaminergic, as well as cholinergic, neurons are reduced in Down's syndrome with Alzheimer pathology.     

大鼠面神经切断及修复后面神经核内胆碱乙酰转移酶的变化

为了研究面神经核胆碱乙酰转移酶在神经损伤及修复后的动态变化 ,用免疫组织化学方法 ,观察了成年大鼠面神经外周切断和即刻端端吻合后面神经核胆碱乙酰转移酶阳性神经元的数量和免疫反应强度的时程变化。结果证明 ,面神经切断后 ,损伤侧面神经核胆碱乙酰转移酶阳性神经元的数量和免疫反应强度均明显下降 ,术后第 7d下降至最低。面神经切断后立即行端端吻合 ,术后 7d内手术侧面神经核胆碱乙酰转移酶阳性神经元的数量和免疫反应强度的下降规律与面神经单纯切断组相同。面神经吻合后 ,术侧面神经核胆碱乙酰转移酶阳性神经元的数量和免疫反应强度的回升最早出现在吻合后第 14 d,术后 3 5 d手术侧面神经核胆碱乙酰转移酶阳性神经元的数量恢复至正常。上述结果提示 ,面神经吻合并不能阻止损伤侧面神经核胆碱乙酰转移酶免疫阳性产物的下降 ;伴随着面神经再支配的发生 ,面神经核胆碱乙酰转移酶免疫阳性产物逐渐恢复正常     

Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis

The authors developed a polyclonal antibody against a fusion protein containing 598 amino acids from a human choline acetyltransferase (ChAT) cDNA and 12 amino acids derived from an expression vector, and examined immunohistochemical reactivity for ChAT in large motor neurons (30 μn and more in somal minimal diameter) of the lumbar spinal cords of four patients with amyotrophic lateral sclerosis (ALS) and of four control cases. In controls, the number of large neurons included in the tissue with a total thickness of 100 μm ranged from 74 to 105 (average 87). About 60–90% (average 80%) of the neurons were positively stained in their perikarya with an anti-human ChAT antibody. In the cases of ALS, the number of large motor neurons was greatly reduced (25–60, average 38). About 4–13% (average 8%) were positively stained. These results indicate that not only large neurons are reduced in number, but also their positivity for ChAT is decreased in the anterior horn of ALS spinal cord.     

Does the release of acetylcholine in septal slices originate from intrinsic cholinergic neurons bearing p75(NTR) receptors? A study using 192 IgG-saporin lesions in rats

In previous studies electrically-evoked release of acetylcholine in septal slices was demonstrated. The present experiment aimed at verifying if this release involved intrinsic neurons bearing p75(NTR) receptors. Long-Evans rats sustained injections of 192 IgG-saporin into the medial septum/diagonal band of Broca (0.8 microg). Sham-operated rats served as controls. Two to 3.5 weeks later, the electrically-evoked release of acetylcholine ([(3)H]ACh) was measured in slices from the lateral septum (LS), medial septum (MS) and diagonal band of Broca (DBB). Choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activity, and monoamine concentrations were measured in the septum, cortex and hippocampus. The lesion extent was also assessed by ChAT immunostaining in a separate series of rats. In the septum, the number of ChAT-positive neurons was depleted dramatically (>90% at the level of the injection site). In the hippocampus, the lesions reduced ChAT and AChE activity by 91% and 84%, respectively. In the cortex, this reduction was weaker (-55% and -47%). In the septal region, the reduction was either weak or not significant. The evoked release of acetylcholine in septal slices was not reduced, except in the slices from the LS (-64%). The effects of physostigmine and atropine confirmed the presence of autoreceptors. Our data exclude that a major part of the acetylcholine released by MS and DBB slices derived from intrinsic neurons bearing p75(NTR) receptors. In the LS, part of the released acetylcholine might be from projections of such neurons located in the LS, MS and/or DBB. These data also suggest that the MS and the DBB may be the target of extrinsic cholinergic innervation that does not bear p75(NTR) receptors.     

Serum neuron-specific enolase in senile dementia of the Alzheimer type

The level of neuron-specific enolase (NSE), a glycolytic enzyme localized in neurons, was measured in the serum of patients with senile dementia of the Alzheimer type (SDAT). No difference was observed between NSE levels in SDAT and in healthy elderly controls of the same age range. No correlation was found between NSE levels and severity of the cognitive deficits. There was a marginally significant negative correlation between age and NSE, younger patients having higher NSE levels. The present results suggest that serum NSE is not a useful biological marker in the senile form of the dementia of the Alzheimer type.     

Short-term forgetting in senile dementia of the Alzheimer's type

Abstract

This study explored the nature of forgetting in a group of patients at the early stages of senile dementia of the Alzheimer's type (SDAT). Two experiments were conducted to test the hypothesis that abnormal forgetting in SDAT is due to a reduction in central processing resources, leading to deficits in maintenance rehearsal.

The first experiment tested the patients' ability to remember consonant trigrams after an interval of 0, 5, 10 or 20 seconds, during which they were either instructed to do nothing, articulate the word “the” repeatedly, reverse pairs of digits or add pairs of digits together. The articulation distractor task caused substantial forgetting with SDAT patients in comparison with minimal forgetting in an elderly control group. They were also clearly impaired with digit reversal and digit addition as distractor tasks, although their forgetting rates were similar to the controls. The second experiment showed a substantial decrement in the SDAT patients' ability to remember consonant trigrams with both tapping and articulation as distractor tasks. Overall, these results support the hypothesis that SDAT patients have insufficent central processing resources available for maintenance rehearsal.     

The septo-hippocampal pathway in patients suffering from senile dementia of Alzheimer's type. Evidence for neuronal plasticity?

In 7 cases of senile dementia of Alzheimer's type (SDAT) and in 7 age-matched controls, nerve cells of the medial septal nuclei (area CH1) and of the vertical limb of the diagonal band of Broca (area CH2) of the right hemisphere were counted in Cresyl-fast-violet-stained serial sections. The granular cells of the ipsilateral fascia dentata were Golgi-stained and dendritic spine density was quantified in 10-micron segments. There was a significant loss of neurons in areas CH1 and CH2 in SDAT cases compared to controls. The spine density of the granular cell dendrites was significantly reduced in the distal parts of the dendrites. In the most proximal part, where cholinergic septal fibers form synapses, the spine density was not significantly different between the two groups. We assume that collateral sprouting of undamaged inputs occurs maintaining a constant number of spines in the proximal segments despite the loss of source neurons within CH1 and CH2.     

Age-related changes in rostral basal forebrain cholinergic and GABAergic projection neurons: relationship with spatial impairment

Both cholinergic and GABAergic projections from the rostral basal forebrain contribute to hippocampal function and mnemonic abilities. While dysfunction of cholinergic neurons has been heavily implicated in age-related memory decline, significantly less is known regarding how age-related changes in codistributed GABAergic projection neurons contribute to a decline in hippocampal-dependent spatial learning. In the current study, confocal stereology was used to quantify cholinergic (choline acetyltransferase [ChAT] immunopositive) neurons, GABAergic projection (glutamic decarboxylase 67 [GAD67] immunopositive) neurons, and total (neuronal nuclei [NeuN] immunopositive) neurons in the rostral basal forebrain of young and aged rats that were first characterized on a spatial learning task. ChAT immunopositive neurons were significantly but modestly reduced in aged rats. Although ChAT immunopositive neuron number was strongly correlated with spatial learning abilities among young rats, the reduction of ChAT immunopositive neurons was not associated with impaired spatial learning in aged rats. In contrast, the number of GAD67 immunopositive neurons was robustly and selectively elevated in aged rats that exhibited impaired spatial learning. Interestingly, the total number of rostral basal forebrain neurons was comparable in young and aged rats, regardless of their cognitive status. These data demonstrate differential effects of age on phenotypically distinct rostral basal forebrain projection neurons, and implicate dysregulated cholinergic and GABAergic septohippocampal circuitry in age-related mnemonic decline.     

不同年龄大鼠斜角带核水平支神经元内TrkA和ChAT的表达——免疫组织化学研究

目的 了解大鼠基底前脑斜角带核水平支神经元内酪氨酸激酶Ａ（ｔｙｒｏｓｉｎｅ ｋｉｎａｓｅ,Ａ,ＴｒｋＡ）、胆碱乙酰化转移酶（ｃｈｏｌｉｎｅ ａｃｅｔｙｌｔｒａｎｓｆｅｒａｓｅ,ＣｈＡＴ）样阳性神经元的生后发育规律及两乾的相互关系。方法 用免疫组织化学方法结合图像分析仪检测大鼠基底前脑斜角带核水平支ＴｒｋＡ、ＣｈＡＴ样阳性神经元的数量、面积和灰度值。结果 ＴｒｋＡ、ＣｈＡＴ分布于基底前脑神经元。生后１ｄ可见ＴｒｋＡ表达,但生后５ｄ才出现ＣｈＡＴ表达。生后２０ｄＴｒｋＡ、ＣｈＡＴ表达至高峰;生后３０ｄ下调,成年时维持相对较高水平。老年鼠ＴｒｋＡ、ＣｈＡＴ样阳性神经元出现萎缩、数量也分别减少３９．７％、３３．３％;胞体平均面积分别减少１５．７％、１２．８％;平均灰度值分别减少２９．９％、９．９％。同时,不同年龄大鼠Ｔ     

82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease

Cholinergic neurons express choline acetyltransferase (ChAT) which synthesizes acetylcholine. We show here for the first time that primate-specific 82-kDa ChAT is expressed in nuclei of cholinergic neurons in human brain and spinal cord; isoform-specific antibodies were used to compare localization patterns and temporal expression of the more abundant 69-kDa ChAT and primate-specific 82-kDa ChAT in necropsy tissues. The 82-kDa ChAT co-localizes with 69-kDa ChAT in well-characterized cholinergic areas, but is also found in the claustrum which does not contain 69-kDa ChAT. Cholinergic neuron function changes with increasing age and are targeted in neurodegenerative diseases such as AD, thus we compared expression and subcellular localization of 69- and 82-kDa ChAT in necropsy brain samples from control subjects of varying ages and from Alzheimer disease (AD) subjects. The 82-kDa ChAT protein was expressed in cholinergic neurons in brain from birth until the eighth decade of life and in AD, but the subcellular staining pattern and proportion of neurons that were immunopositive changed with increasing age and in AD.     

大鼠Meynert基底核TrkA和ChAT的表达

本实验用免疫组织化学方法研究了 Trk A在大鼠 Meynert基底核的分布及 Trk A、Ch AT免疫反应神经元的生后发育及两者表达的相互关系。用图像分析仪检测 Meynert基底核 Trk A-、Ch AT-IR神经元的数量、截面积和灰度值。结果表明 :　Tr-k A、Ch AT分布于 Meynert基底核神经元。生后 1d可见 Trk A表达 ,但未见 Ch AT表达 ;生后 5 d方出现 Ch AT表达 ;生后 2 0 dTrk A、Ch AT表达达高峰 ;生后 3 0 d下降 ,到成年时维持相对较高水平。老龄鼠 Trk A-、Ch AT-IR神经元萎缩 ,数量分别减少 41.3 8%和 5 1.61% ,胞体平均截面积分别减少 3 9.4%和 3 0 .4% ,平均灰度值分别减少 11.8%和 9.9%。大鼠 Trk A-、Ch AT-IR神经元截面积呈正相关。大鼠 Meynert基底核神经元 Trk A表达早于 Ch AT表达 ,从生后 5 d开始 ,Trk A、Ch AT表达有相似的时间模式。 Trk A可能参与 Meynert基底核胆碱能神经元的发育、分化、成熟和老化。老龄鼠 Trk A、Ch AT表达下降可能是老年动物和老年性痴呆病人基底前脑胆碱能神经元变性的易感性增加的原因之一     

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains

Nicotinic cholinergic receptors were measured in human frontal cortex using [3H]nicotine and [3H]acetylcholine (in the presence of atropine) as receptor ligands. A parallel marked reduction in number of [3H]nicotine (52%; P less than 0.01) and [3H]acetylcholine (-55%; P less than 0.05) binding was found in the frontal cortex of Alzheimer brains (AD/SDAT) when compared to age-matched control brains. As a comparison the number of muscarinic receptors was quantified using [3H]quinuclidinyl benzilate and found to be significantly increased (+23%; less than 0.01) in AD/SDAT compared to controls.     

Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice

Reelin (RELN) is a key molecule for the regulation of neuronal migration in the developing CNS. The reeler mice, which have spontaneous autosomal recessive mutation in the RELN gene, reveal multiple defects in brain development. Morphological, neurochemical and behavioral alterations have been detected in heterozygous reeler (HR) mice, suggesting that not only the presence, but also the level of RELN influences brain development. Several studies implicate an involvement of RELN in the pathophysiology of neuropsychiatric disorders in which an alteration of the cholinergic cortical pathways is implicated as well. Thus, we decided to investigate whether the basal forebrain (BF) cholinergic system is altered in HR mice by examining cholinergic markers at the level of both cell body and nerve terminals. In septal and rostral, but not caudal, basal forebrain region, HR mice exhibited a significant reduction in the number of choline acetyltransferase (ChAT) immunoreactive (ir) cell bodies compared with control mice. Instead, an increase in ChAT ir neurons was detected in lateral striatum. This suggests that an alteration in ChAT ir cell migration which leads to a redistribution of cholinergic neurons in subcortical forebrain regions occurs in HR mice. The reduction of ChAT ir neurons in the BF was paralleled by an alteration of cortical cholinergic nerve terminals. In particular, the HR mice presented a marked reduction of acetylcholinesterase (AChE) staining accompanied by a small reduction of cortical thickness in the rostral dorsomedial cortex, while the density of AChE staining was not altered in the lateral and ventral cortices. Present results show that the cholinergic basalo-cortical system is markedly, though selectively, impaired in HR mice. Rostral sub-regions of the BF and rostro-medial cortical areas show significant decreases of cholinergic neurons and innervation, respectively.     

VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type

Biochemical parameters were determined in autopsy material from several brain regions of thirteen patients with Alzheimer's disease/senile dementia of Alzheimer type (AD/SDAT) (mean age 75 years) and from brains of ten age-matched controls (mean age 76 years). Choline acetyltransferase specific activity was significantly lower in the nucleus caudatus, putamen, left thalamus, hippocampus and the cortex from gyrus hippocampus and the temporal lobe in AD/SDAT, acetylcholinesterase specific activity was significantly lower in the hippocampus, parietal and left frontal lobe in AD/SDAT samples than in corresponding samples from aged-matched controls. A compensatory increase of muscarinic receptors was found in the nucleus caudatus and left frontal lobe samples in AD/SDAT. Guanylate cyclase activity was not significantly altered in AD/SDAT in the brain regions examined. The basal, non-stimulated activity of adenylate cyclase was significantly (p less than 0.05) elevated in hippocampus samples from AD/SDAT patients and the enzyme activity stimulated by the vasoactive intestinal polypeptide VIP (2 microM) or forskolin (10 microM) was also elevated in AD/SDAT although not significantly.